Clinical Trials Directory

Trials / Completed

CompletedNCT04588532

Characterization of BAM8-22 as a New Surrogate Model of Non-histaminergic Itch

Characterization of Bovine Adrenal Medulla (BAM8-22) as a New Surrogate Model of Non-histaminergic Itch

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Aalborg University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

With this experiment, the experimenter wish to asses if substance BAM8-22 (Bovine Adrenal Medulla) induce non-histaminergic itch.

Detailed description

With this experiment, the experimenter wish to establish if the substance BAM8-22 (Bovine Adrenal Medulla) induce a non-histaminergic itch by using the antihistamine Doxepin. The experimenter will also compare itch and the response to antihistamine of BAM8-22, histamine and cowhage.

Conditions

Interventions

TypeNameDescription
DRUGBAM8-22Bovine Adrenal Medulla will be applied to 2 previously determined area on the volar forearm (one alone and one in combination with doxepin)
DRUGHistaminehistamine will be applied to 2 previously determined area on the volar forearm (one alone and one in combination with doxepin)
DRUGCowhage (Mucuna Pruriens)cowhage spicules will be applied to 2 previously determined area on the volar forearm (one alone and one in combination with doxepin)
DRUGDoxepinDoxepin cream (antihistamine) will be applied in 4 areas on the volar forearm

Timeline

Start date
2020-10-01
Primary completion
2021-05-01
Completion
2021-06-01
First posted
2020-10-19
Last updated
2021-07-21

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04588532. Inclusion in this directory is not an endorsement.